MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock
Identity
- Security key
- 18761
- Ticker
- MRVI
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-11-20
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- MRVI
Detail
Enriched 2026-08-14 20:47
- Market cap
- $861,159,570.1
- Shares outstanding (class)
- 147,506,164
- Shares outstanding (weighted)
- 148,989,545
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 416
- Location
- SAN DIEGO, CA
- Homepage
- https://www.maravai.com
- Description
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.